Laptop Charger Leaking Fluid, Neem Leaf In Yoruba, Articles A

This Court has considered all the parties' arguments. RIDGELAND, MS 39157-6077. Access this case on the Michigan Eastern District Court's Electronic Court Filings (ECF) System. The NPI number of this provider is 1336243393 and was assigned on September 2006. By continuing to use this website, you agree to UniCourts General Disclaimer, Terms of Service, And by breaching the Agreement, AIS caused BCBS to wrongfully pay the S9328 code. 869, Km 2.0, Calle 19, Solar 1-A Palmas Industrial Park Catao, P.R. [21-30534] (SEP) [Entered: 09/15/2021 10:19 AM], APPEARANCE FORM for the court's review. How Much Do Advanced Infusion Solutions Jobs Pay per Year? Cenac v. Murray,609 So.2d 1257, 1272 (Miss. Id. Bond Pharmacy, Incorporated, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare, SUPPLEMENTAL ELECTRONIC RECORD ON APPEAL FILED. 00962. 4:22-CV-12577 | 2022-10-26, U.S. District Courts | Contract | . See Order [61]. [21-30534] (SEP) [Entered: 09/15/2021 10:20 AM], APPEARANCE FORM FILED by Attorney Roberta Louise Burns for Appellant Randy Denning in 21-30534. AIS moves to dismiss BCBS and AHS's counter claims under Rule 12(b)(6). No Electronic ROA deadline satisfied. But they disagree as to whether AIS breached it. Id. D/B/A ADVANCED INFUSION CARE Court:United States District Court, Eastern District of Louisiana Date published: Jul 30, 2021 CitationsCopy Citation Civil Action 21-774 (E.D. Thus, the Court denies AIS's motion on this claim. Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. AIS is a specialty pharmacy that provides home infusion therapy, which infuses patients' pain medications into the intrathecal space surrounding their spinal cord through surgically implanted pumps. A subscription to PACER is required. Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017. 2:23-CV-00124 | 2023-01-31, U.S. District Courts | Property | (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - Home Infusion Therapy Facility Participation Agreement, #3 Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, #4 Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez) (Winsten, I.) BOND PHARMACY INC. 623 HIGHLAND COLONY PKWY STE 100. $52,000 - $65,999 10% of jobs $66,000 - $79,999 13% of jobs The average salary is $93,518 a year $80,000 - $93,999 13% of jobs $94,000 - $107,999 12% of jobs BCBS and AHS, on the other hand, allege the Agreement permitted AIS to bill a per diem rate under the S9328 code "when it performed intrathecal pain pump fill/refills or other infusions in the [m]ember's home or equivalent setting and provided ongoing services, such as medical supervision, care coordination, nursing, patient or caregiver training, and patient support." Post author: Post published: 22/06/2022 Post category: brenda payne hendersonville, tn Post comments: criminal fraternities 18th century criminal fraternities 18th century